ALPS ETF TR - MED BREAKTHGH (SBIO)

CUSIP: 00162Q593

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / MED BREAKTHGH
Total 13F shares
1,438,262
Share change
+142,784
Total reported value
$51,309,167
Put/Call ratio
15%
Price per share
$35.75
Number of holders
37
Value change
+$5,137,206
Number of buys
15
Number of sells
12

Security key

00162Q593

Report period

Q1 2024

Institutions

37

Top holders

10

Top shareholders of SBIO - ALPS ETF TR - MED BREAKTHGH (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q1 2024

As of 31 Mar 2024, ALPS ETF TR - MED BREAKTHGH (SBIO) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,438,262 shares. The largest 10 holders included DAVENPORT & Co LLC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS Group AG, WELLS FARGO & COMPANY/MN, NTV Asset Management LLC, Phoenix Wealth Advisors, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Strategic Financial Services, Inc,, and LPL Financial LLC. This page lists 37 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
34
Q1 2024 holders
37
Holder diff
3
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 Value $ Q1 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .